Production of cheaper, longer-lasting vaccines that don’t need refrigeration

via Medicalxpress

Article Highlights

Vaccines currently need to be refrigerated during transport and storage and have a short shelf-life, in some cases as little as a few months. This can be a problem in low-income countries and remote areas with no electricity. Some vaccines also rely on additional pharmacological or immunological substances, called adjuvants, to boost their desired immune response, which may have unwanted side-effects, such as allergies
“The vaccines that are currently available require constant cold storage, meaning they rely on a temperature-controlled supply chain, which constitutes over 80% of their cost. We have developed a novel technology to produce vaccines which require no refrigeration and have a shelf life of many years. These vaccines could be transported to regions of the world without electricity and refrigeration.”
Vaca and a team of researchers adapted a strategy used by insect viruses that allows them to survive outside of their host for extended periods of time
They found that mice injected with PH(1-110)GFP produced anti-GFP antibodies and showed a strong immune response, similar to one observed in mice injected with GFP and an adjuvant. As GFP on its own does not create a strong immune response, an adjuvant would normally be needed. Anti-GFP antibodies remained in the blood of vaccinated mice after 24 weeks, indicating the production of a lasting immune response
The authors also found that PH(1-110)GFP particles stored as dry powder at room temperature still generated antibodies when they were used to vaccinate mice after up to twelve months of storage. The results suggest that PH(1-110) could enable the production of thermostable vaccines that generate a sufficient immune response without the need for an adjuvant, or refrigeration
Our technology opens up the possibility of reducing the cost of conservation and distribution of vaccines by about 80% - the cost of the temperature-controlled supply chain

The Complete Story: New method to enable the production of cheaper, longer-lasting vaccines

National Autonomous University of Mexico

Go deeper with Bing News on:

Vaccines

Negativity About Vaccination On Twitter Increases After COVID-19 Vaccines Become Available
Following the availability of COVID-19 vaccines, there was a noticeable surge in negativity surrounding vaccines on Twitter. Researchers at the ESCMID Global Congress (formerly ECCMID) in Barcelona, ...
WHO picks JN.1 variant for next set of COVID vaccines
The World Health Organization has recommended updating COVID-19 vaccine formulations to reflect the dominant SARS-CoV-2 variant, JN.1. Read more here.
Vaccines saved at least 154 million lives in 50 years—WHO
Global immunization efforts have saved at least 154 million lives in the past 50 years, the World Health Organization (WHO) said Wednesday, adding that most of those to benefit were infants. That is ...
Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024
Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, presented positive data from three key studies of its ...
DRC is seeing its worst mpox outbreak — but has no vaccines or treatments yet. Why?
With nearly 5,000 cases reported so far this year — and concerns about a new strain — the Democratic Republic of Congo is considering the declaration of a public health emergency.

Go deeper with Google Headlines on:

Vaccines

[google_news title=”” keyword=”vaccines” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]

Go deeper with Bing News on:

Vaccine production

Avian Flu Threat Still Low and Vaccine Measures Are Ready
One person in the United States has been infected after exposure to a cow with avian flu, but no human-to-human transmission has occurred.
GSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech are being dragged into another round of mRNA litigation by GSK. | GSK filed ...
Study confirms effectiveness of bivalent COVID-19 vaccine
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less ...
Demand for the cholera vaccine is soaring – this company might have a solution
In the global race to provide enough vaccines to tackle the ever-growing threat posed by cholera, one company is leading the field.
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
Under the terms of the contract, Applied DNA will supply Linea™ DNA IVT templates to HDT Bio for use in conjunction with its LION™ formulated repRNA (self-replicating RNA) vaccination platform. The ...

Go deeper with Google Headlines on:

Vaccine production

[google_news title=”” keyword=”vaccine production” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]

What's Your Reaction?

Don't Like it!

I Like it!

Production of cheaper, longer-lasting vaccines that don’t need refrigeration

National Autonomous University of Mexico

The Latest Updates from Bing News & Google News

Go deeper with Bing News on:

Vaccines

Go deeper with Google Headlines on:

Vaccines

Go deeper with Bing News on:

Vaccine production

Go deeper with Google Headlines on:

Vaccine production

Leave a Reply